Miguel Madero - Net Worth and Insider Trading

Miguel Madero Net Worth

The estimated net worth of Miguel Madero is at least $480,528 dollars as of 2024-06-22. Miguel Madero is the Director of FibroGen Inc and owns about 425,246 shares of FibroGen Inc (FGEN) stock worth over $480,528. Details can be seen in Miguel Madero's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Miguel Madero has not made any transactions after 2015-12-08 and currently still holds the listed stock(s).

Transaction Summary of Miguel Madero

To

Miguel Madero Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Miguel Madero owns 2 companies in total, including FibroGen Inc (FGEN) , and Agritek Holdings Inc (AGTK) .

Click here to see the complete history of Miguel Madero’s form 4 insider trades.

Insider Ownership Summary of Miguel Madero

Ticker Comapny Transaction Date Type of Owner
FGEN FibroGen Inc 2015-12-08 director
AGTK Agritek Holdings Inc 2004-02-01 director

Miguel Madero Latest Holdings Summary

Miguel Madero currently owns a total of 1 stock. Miguel Madero owns 425,246 shares of FibroGen Inc (FGEN) as of December 8, 2015, with a value of $480,528.

Latest Holdings of Miguel Madero

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FGEN FibroGen Inc 2015-12-08 425,246 1.13 480,528

Holding Weightings of Miguel Madero


Miguel Madero Form 4 Trading Tracker

According to the SEC Form 4 filings, Miguel Madero has made a total of 0 transactions in FibroGen Inc (FGEN) over the past 5 years. The most-recent trade in FibroGen Inc is the sale of 40,386 shares on December 8, 2015, which brought Miguel Madero around $1 Million.

Insider Trading History of Miguel Madero

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Miguel Madero Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Miguel Madero Ownership Network

Ownership Network List of Miguel Madero

No Data

Ownership Network Relation of Miguel Madero

Insider Network Chart

Miguel Madero Owned Company Details

What does FibroGen Inc do?

Who are the key executives at FibroGen Inc?

Miguel Madero is the director of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .

FibroGen Inc (FGEN) Insider Trades Summary

Over the past 18 months, Miguel Madero made no insider transaction in FibroGen Inc (FGEN). Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 30,120 shares made by Thane Wettig , a net sale of 89,934 shares made by Enrique A Conterno , and a net sale of 38,683 shares made by Christine Chung .

In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 22,123 shares, with a net purchase of 22,123 shares. During the past 18 months, 241,563 shares of FibroGen Inc (FGEN) were sold and 72,123 shares were bought by its insiders, resulting in a net sale of 169,440 shares.

FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

FibroGen Inc Insider Transactions

No Available Data

Miguel Madero Mailing Address

Above is the net worth, insider trading, and ownership report for Miguel Madero. Currently GuruFocus does not have mailing address information for Miguel Madero.

Discussions on Miguel Madero

No discussions yet.